Increased conceptual switching by dopaminergic treatment in patients with Parkinson's disease

被引:5
作者
Tiedt, Hannes O. [1 ]
Ehlen, Felicitas [1 ,2 ]
Klostermann, Fabian [1 ,3 ]
机构
[1] Charite Univ Med Berlin, Dept Neurol, Motor & Cognit Grp, Campus Benjamin Franklin CBF, Hindenburgdamm 30, D-12203 Berlin, Germany
[2] Jud Krankenhaus Berlin, Dept Psychiat, Heinz Galinski Str 1, D-13347 Berlin, Germany
[3] Humboldt Univ, Berlin Sch Mind & Brain, Unter Linden 6, D-10099 Berlin, Germany
关键词
Parkinson's disease; Verbal fluency; Dopamine; Switches; Cluster; Semantic spreading activation; SPREADING-ACTIVATION THEORY; DEEP BRAIN-STIMULATION; VERBAL FLUENCY; WORKING-MEMORY; COGNITIVE PERFORMANCE; SEMANTIC ACTIVATION; DECISION-MAKING; MODULATION; LEVODOPA; OSCILLATIONS;
D O I
10.1016/j.bandc.2020.105611
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cognitive changes including reduced word production in verbal fluency (VF) tasks are frequently observed in Parkinson's disease (PD) with ambiguous effects of dopaminergic medication on these symptoms. Here, we studied the impact of dopaminergic medication on specific cognitive components underlying VF task performance in 21 participants with PD on their regular medication and following dopamine withdrawal compared with healthy controls. We used temporal cluster analysis (TCA) to differentiate phases of VF output relating to fast automatic lexical activation ('clusters') and slower attention-demanding shifts ('switches'). Dopaminergic medication led to increased switching and, in non-alternating VF tasks, to the formation of smaller and shorter word clusters. The number of switches was correlated with higher cognitive scores and showed an inverse relationship with VF error rates. Increased switching operations during VF task performance can be interpreted in view of nigrostriatal dopaminergic roles for balancing system state versus change propensities. The additional effect on word clustering suggests a modulation of semantic spreading activation mechanisms underlying lexical search, presumably involving non-nigrostriatal, e.g., mesocortical dopaminergic networks.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Sleep Attacks in Patients With Parkinson's Disease on Dopaminergic Medications: A Systematic Review
    Yeung, Eugene Y. H.
    Cavanna, Andrea E.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2014, 1 (04): : 307 - 316
  • [42] Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease
    Fern-Pollak, L
    Whone, AL
    Brooks, DJ
    Mehta, MA
    NEUROPSYCHOLOGIA, 2004, 42 (14) : 1917 - 1926
  • [43] Increased plasma neurotensin concentrations in patients with Parkinson's disease
    Schimpff, RM
    Avard, C
    Fénelon, G
    Lhiaubet, AM
    Tennezé, L
    Vidailhet, M
    Rostène, W
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 (06) : 784 - 786
  • [44] A study of dopaminergic sensitivity in Parkinson's disease: Comparison in ''de novo'' and levodopa-treated patients
    Llau, ME
    Durrieu, G
    Tran, MA
    Senard, JM
    Rascol, O
    Montastruc, JL
    CLINICAL NEUROPHARMACOLOGY, 1996, 19 (05) : 420 - 427
  • [45] Dopaminergic Therapy Increases Go Timeouts in the Go/No-Go Task in Patients with Parkinson's Disease
    Yang, Xue Q.
    Lauzon, Brian
    Seergobin, Ken N.
    MacDonald, Penny A.
    FRONTIERS IN HUMAN NEUROSCIENCE, 2018, 11
  • [46] The Effect of Dopaminergic Therapy in Parkinson's Disease: A Graph Theory Analysis
    Siva, Karthik
    Ponnusamy, Palanisamy
    Chavda, Vishal
    Montemurro, Nicola
    BRAIN SCIENCES, 2025, 15 (04)
  • [47] Influence of depressive symptoms on dopaminergic treatment of Parkinson's disease
    Hanganu, Alexandru
    Degroot, Clotilde
    Monchi, Oury
    Bedetti, Christophe
    Mejia-Constain, Beatriz
    Lafontaine, Anne-Louise
    Chouinard, Sylvain
    Bruneau, Marie-Andree
    FRONTIERS IN NEUROLOGY, 2014, 5
  • [48] Dopaminergic influences on the P300 abnormality in Parkinson's disease
    Sohn, YH
    Kim, GW
    Huh, K
    Kim, JS
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 158 (01) : 83 - 87
  • [49] Beta burst dynamics in Parkinson's disease OFF and ON dopaminergic medication
    Tinkhauser, Gerd
    Pogosyan, Alek
    Tan, Huiling
    Herz, Damian M.
    Kuehn, Andrea A.
    Brown, Peter
    BRAIN, 2017, 140 : 2968 - 2981
  • [50] Precision Dopaminergic Treatment in a Cohort of Parkinson's Disease Patients Carrying Autosomal Recessive Gene Variants: Clinical Cohort Data and a Mini Review
    Koros, Christos
    Simitsi, Athina-Maria
    Papagiannakis, Nikolaos
    Bougea, Anastasia
    Antonelou, Roubina
    Pachi, Ioanna
    Sfikas, Evangelos
    Stanitsa, Evangelia
    Angelopoulou, Efthalia
    Constantinides, Vasilios C.
    Papageorgiou, Sokratis G.
    Potagas, Constantin
    Stamelou, Maria
    Stefanis, Leonidas
    NEUROLOGY INTERNATIONAL, 2024, 16 (04): : 833 - 844